Diadenosine‐5‐phosphate exerts A1‐Receptor‐mediated proarrhythmic effects in rabbit atrial myocardium

Authors:

Abstract
Diadenosine polyphosphates have been described to be present in the myocardium and exert purinergic‐ and nonreceptor‐mediated effects. Since the electrophysiological properties of atrial myocardium are effectively regulated by A1 receptors, we investigated the effect of diadenosine pentaphosphate (Ap5A) in rabbit myocardium. Parameters of supraventricular electrophysiology and atrial vulnerability were measured in Langendorff‐perfused rabbit hearts. Muscarinic potassium current (IK(ACh/Ado)) and ATP‐sensitive potassium current (IK(ATP)) were measured by using the whole‐cell voltage clamp method. Ap5A prolonged the cycle length of spontaneously beating Langendorff perfused hearts from 225±14 (control) to 1823±400 ms (Ap5A 50 μM; n=6; Pn=6). Ap5A1 μM reduced AERP (100 μM, 58±11 ms; n=6). Extrastimuli delivered to hearts perfused with Ap5A‐ or adenosine ( μM)‐induced atrial fibrillation, the incidence of which correlated to the concentration added to the perfusate. The selective A1‐receptor antagonist CPX (20 μM) inhibited the Ap5A‐ and adenosine‐induced decrease of AERP. Atrial fibrillation was no longer observed in the presence of CPX. The described Ap5A‐induced effects in the multicellular preparation were enhanced by dipyridamole (10 μM), which is a cellular adenosine uptake inhibitor. Dipyridamole‐induced enhancement was inhibited by CPX. Ap5A (1 mM) did neither induce IK(Ado) nor IK(ATP). No effect on activated IK(Ado/ATP) was observed in myocytes superfused with Ap5A. However, effluents from Langendorff hearts perfused with Ap5A 100 μM activated IK(Ado) by using A1 receptors. Ap5A did not activate A1 receptors in rabbit atrial myocytes. The Ap5A induced A1‐receptor‐mediated effects on supraventricular electrophysiology and vulnerability suggest that in the multicellular preparation Ap5A is hydrolyzed to yield adenosine, which acts via A1 receptors. An influence on atrial electrophysiology or a facilitation of atrial fibrillation under conditions resulting in increased interstitial Ap5A concentrations might be of physiological/pathophysiological relevance. British Journal of Pharmacology (2003) 139, 1265–1272. doi:10.1038/sj.bjp.0705361

This publication has 24 references indexed in Scilit: